Skip to main content
Fig. 5 | EJNMMI Research

Fig. 5

From: I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinoma

Fig. 5

%IA/L of serum was plotted following injection of 10 mg I-124 codrituzumab alone (circle) or co-infused with 2.5 mg/kg (triangles) or 5 mg/kg (squares). The larger mass amount of antibody resulted in significant mass-dependent changes with longer half-life and greater AUC than the 10 mg injection (Table 2). There was an overlap of the clearance curves for the 2.5 and 5 mg/kg co-infused mass

Back to article page